Log in

Globus Medical Stock Forecast, Price & News

+0.38 (+0.78 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $49.21
50-Day Range
MA: $54.51
52-Week Range
Now: $49.21
Volume441,859 shs
Average Volume950,855 shs
Market Capitalization$4.81 billion
P/E Ratio57.22
Dividend YieldN/A
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. Its spine product portfolio includes a range of implant and surgical approach options that could be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers imaging, navigation, and robotic assisted surgery technology solutions, as well as motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures. In addition, it provides regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. Further, the company offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems. Additionally, it distributes human cell, tissue, and cellular and tissue based products. The company sells its implants and related disposables primarily to hospitals through direct sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.
Read More
Globus Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.81 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$785.37 million
Cash Flow$1.98 per share
Book Value$14.05 per share


Net Income$155.21 million


Market Cap$4.81 billion
Next Earnings Date11/4/2020 (Estimated)
+0.38 (+0.78 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GMED News and Ratings via Email

Sign-up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Globus Medical (NYSE:GMED) Frequently Asked Questions

How has Globus Medical's stock been impacted by Coronavirus (COVID-19)?

Globus Medical's stock was trading at $38.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GMED shares have increased by 29.3% and is now trading at $49.21.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Globus Medical?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Globus Medical

When is Globus Medical's next earnings date?

Globus Medical is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Globus Medical

How were Globus Medical's earnings last quarter?

Globus Medical Inc (NYSE:GMED) released its quarterly earnings data on Wednesday, August, 5th. The medical device company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.18. The medical device company earned $148.92 million during the quarter, compared to the consensus estimate of $99.77 million. Globus Medical had a return on equity of 9.58% and a net margin of 11.90%.
View Globus Medical's earnings history

What price target have analysts set for GMED?

13 brokers have issued 12-month price objectives for Globus Medical's stock. Their forecasts range from $53.00 to $67.00. On average, they anticipate Globus Medical's share price to reach $60.15 in the next twelve months. This suggests a possible upside of 22.2% from the stock's current price.
View analysts' price targets for Globus Medical

Are investors shorting Globus Medical?

Globus Medical saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 1,360,000 shares, a drop of 30.3% from the August 31st total of 1,950,000 shares. Based on an average daily volume of 852,300 shares, the short-interest ratio is currently 1.6 days. Currently, 1.8% of the shares of the stock are sold short.
View Globus Medical's Short Interest

Who are some of Globus Medical's key competitors?

What other stocks do shareholders of Globus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), Crowdstrike (CRWD), Okta (OKTA), Trade Desk (TTD), Tesla (TSLA), Square (SQ), Mastercard (MA), Teladoc Health (TDOC) and Zynga (ZNGA).

Who are Globus Medical's key executives?

Globus Medical's management team includes the following people:
  • Mr. David C. Paul, Co-Founder & Exec. Chairman (Age 52)
  • Mr. David M. Demski, CEO & Director (Age 61)
  • Mr. Anthony L. Williams, Pres & Corp. Sec. (Age 48)
  • Mr. David D. Davidar, Co-Founder & Director (Age 53)
  • Mr. Daniel T. Scavilla, CFO, Exec. VP & Chief Commercial Officer (Age 54)

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

Who are Globus Medical's major shareholders?

Globus Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.17%), Nordea Investment Management AB (1.23%), Nuance Investments LLC (1.21%), GW&K Investment Management LLC (1.01%), Marathon Asset Management LLP (0.92%) and Goldman Sachs Group Inc. (0.90%). Company insiders that own Globus Medical stock include Anthony L Williams, David D Davidar, James R Tobin, Kelly Huller and Robert Andrew Douglas.
View institutional ownership trends for Globus Medical

Which major investors are selling Globus Medical stock?

GMED stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Nuance Investments LLC, Epoch Investment Partners Inc., Prudential Financial Inc., Nuveen Asset Management LLC, AQR Capital Management LLC, Fort Washington Investment Advisors Inc. OH, and Charles Schwab Investment Management Inc.. Company insiders that have sold Globus Medical company stock in the last year include David D Davidar, James R Tobin, and Kelly Huller.
View insider buying and selling activity for Globus Medical

Which major investors are buying Globus Medical stock?

GMED stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Marathon Asset Management LLP, Kayne Anderson Rudnick Investment Management LLC, Bank of America Corp DE, TD Asset Management Inc., Intrepid Capital Management Inc., Raymond James & Associates, and Boston Trust Walden Corp.
View insider buying and selling activity for Globus Medical

How do I buy shares of Globus Medical?

Shares of GMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Globus Medical's stock price today?

One share of GMED stock can currently be purchased for approximately $49.21.

How big of a company is Globus Medical?

Globus Medical has a market capitalization of $4.81 billion and generates $785.37 million in revenue each year. The medical device company earns $155.21 million in net income (profit) each year or $1.68 on an earnings per share basis. Globus Medical employs 2,000 workers across the globe.

What is Globus Medical's official website?

The official website for Globus Medical is www.globusmedical.com.

How can I contact Globus Medical?

Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The medical device company can be reached via phone at 610-930-1800 or via email at [email protected]

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.